Skip Navigation Links

Faculty

Research

Systems

Infrastructure
 Clinical Research Networks
 Research Centres
 Biomedical Research Centres
 Biomedical Research Units
 Patient Safety Research Centres
 Experimental Cancer Medicine Centres
 Clinical Research Facilities for Experimental Medicine 
 HTCs
 CLAHRCs
 Research Capability Funding
 NOCRI
 Diagnostic Evidence Co-operatives

Patient & Public Awareness

Working with Industry

Research Databases

About Us

 
  providing the NHS with the support and facilities it needs for first class research
 
Clinical Research Facilities for Experimental Medicine


The NIHR funds Clinical Research Facilities (CRFs) for Experimental Medicine to help speed up the translation of scientific advances for the benefit of patients. 

CRFs are purpose-built, cutting-edge facilities, with specialist clinical, research and support staff, in locations where universities and NHS Trusts work together on dedicated programmes of patient-orientated experimental medicine research.

Since its establishment in 2006 the NIHR has worked in partnership with other major funders under the umbrella of the UK Clinical Research Collaboration (UKCRC) to facilitate the translation of scientific advances into benefits for patients through the establishment of dedicated purpose-built CRFs. Capital funding for buildings and equipment has been provided by the UKCRC partners, including the NIHR. The NIHR funded the necessary recurrent NHS infrastructure costs of these CRFs such as clinical research nurses, technicians, and facility running costs, via a number of schemes.

New NIHR funding for CRFs
In October 2011 the NIHR launched a new open competition for funding applications to ‘renew and refresh’ NIHR funding for CRFs for Experimental Medicine.

An expert national Assessment Panel reviewed applications from NHS organisations in England against clear assessment criteria. The Panel comprised national experts in experimental medicine and in running facilities to support its conduct. 

Nineteen applications were successful. These were announced on 1 March 2012DH press release.

The successful CRFs will receive a total of £102 million between 1 September 2012 until 31 March 2017. The NIHR funding for CRFs provides a key contribution to NHS collaboration with industry in experimental medicine, an area of increasing importance given the evolving drug development model and focus on open innovation. This was recently highlighted in the Government’s Strategy for UK Life Sciences.

NHS Trusts receiving NIHR funding for Clinical Research Facilities for Experimental Medicine

NHS Organisation

 Funding awarded

Alder Hey Children’s NHS Foundation Trust

£2,000,000

Brighton and Sussex University Hospitals NHS Trust

£3,000,000

Cambridge University Hospitals NHS Foundation Trust*

£10,849,043

Central Manchester University Hospitals NHS Foundation Trust

£5,500,000

The Christie NHS Foundation Trust

£4,500,000

Guy’s and St Thomas’ NHS Foundation Trust

£5,643,244

Imperial College Healthcare NHS Trust

£10,885,958

Leeds Teaching Hospitals NHS Trust

£500,000

Moorfields Eye Hospital NHS Foundation Trust

£5,315,730

The Newcastle Upon Tyne Hospitals NHS Foundation Trust*

£4,000,000

Oxford University Hospitals NHS Trust

£3,738,298

Royal Devon and Exeter NHS Foundation trust

£5,738,298

The Royal Marsden NHS Foundation Trust*

£2,812,128

Sheffield Teaching Hospitals NHS Foundation Trust

£3,111,844

South London and Maudsley NHS Foundation trust*

£4,738,298

University College London Hospitals NHS Foundation Trust

£5,500,000

University Hospitals Birmingham NHS Foundation Trust*

£12,812,956

University Hospital of South Manchester NHS Foundation Trust

£2,500,000

University Hospital Southampton NHS Foundation Trust

£9,244,166

                            £102, 389,962 

*includes some existing support to these Clinical Research Facilities, which is subsumed in this future funding.

 
NIHR briefing document

4.4 Clinical Research Facilities for Experimental Medicine